DAS Srl Exhibits Range of Fully Automated Systems at MEDLAB Middle East 2020
|
By LabMedica International staff writers Posted on 06 Feb 2020 |
|
Illustration
DAS Srl (Lazio, Italy) displayed the AP22 IF BLOT ELITE system and its lineup of standalone instruments at MEDLAB Middle East, one of the world’s major events in the field of medical diagnostics that was held in Dubai World Trade Center and attended by thousands of visitors from over 135 countries.
At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.
DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.
DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).
Related Links:
DAS Srl
At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.
DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.
DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).
Related Links:
DAS Srl
New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Latest MEDLAB 2020 News
- Diagnostica Stago Displays STA Compact Max and STA Satellite Max Analyzers at MEDLAB
- GeneMatrix Promotes Sex and Respiratory Infection Testing Products at MEDLAB
- Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020
- New Technology that Detects MRSA in 15 Minutes Introduced at MEDLAB Middle East 2020
- Vircell Exhibits Its New VirClia Lotus and qSPEED-OLIGO Systems at MEDLAB
- Randox Showcases New All-In-One Solution for Molecular Diagnostics at MEDLAB Middle East 2020
- EKF Diagnostics Displays POC Analyzers for Hemoglobin, HbA1c And Lactate at MEDLAB Middle East
- Erba Mannheim Launches New Electrolyte Analyzer with Maintenance-free Electrodes at MEDLAB 2020
- MEDLAB Middle East 2020 Addresses Future of Laboratory Medicine
Channels
Clinical Chemistry
view channel
Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms
Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more
Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy
Routine blood tests that measure low-density lipoprotein (LDL), commonly known as “bad” cholesterol, are widely used to guide lipid-lowering therapy, but they do not always provide a complete picture of... Read more
AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers
Cardiovascular diseases are a leading cause of death, responsible for nearly 20 million deaths each year. Timely triage of myocardial infarction and heart failure hinges on rapid cardiac biomarker measurement,... Read more
Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read moreMolecular Diagnostics
view channel
Urine-Based Assay Predicts Severe Dengue Risk Early
Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses. Only about 2% to 5% of patients develop... Read more
CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Sclerosis
Multiple sclerosis affects more than 2.9 million people worldwide and requires ongoing evaluation of disease activity to guide care. Routine monitoring often depends on magnetic resonance imaging (MRI),... Read more
Ultrasensitive Assay Tracks Resistance Mutations MRD Monitoring
Ultrasensitive circulating tumor DNA assessment is being applied to predict and track response to immunotherapy and to detect relapse across multiple solid tumors. Monitoring resistance mutations such... Read more
Extracellular Vesicle RNA Biomarkers Enable Noninvasive IBD Diagnosis and Monitoring
Inflammatory bowel disease (IBD) is a chronic, relapsing gastrointestinal condition whose incidence is rising in industrialized and newly industrialized countries, with prevalence in early‑industrialized... Read moreHematology
view channel
Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
Anemia detected in routine care can signal underlying pathology and is frequently encountered in adults. Because it is defined by hemoglobin levels below the normal range, it is often evaluated with red... Read more
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
Chronic myelomonocytic leukemia (CMML) is a rare blood cancer in which acquired genetic mutations in bone marrow stem cells drive disease. Stem cell transplantation is the only curative option but carries... Read more
Immunology
view channel
Study Finds Influenza Often Undiagnosed in Winter Deaths
Seasonal influenza drives substantial excess mortality, yet its contribution is often obscured when infections go undiagnosed near the time of death. Many deaths occur outside hospitals or in older adults... Read more
Combined Screening Approach Identifies Early Leprosy Cases
Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read more
Microbiology
view channel
RNA-Based Workflow Identifies Active Skin Microbes for Dermatology Research
Human skin carries diverse microbial communities that influence barrier function and inflammation, yet identifying which organisms are metabolically active has been challenging. DNA-based surveys catalog... Read more
Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspots
Intensive care units face persistent threats from hospital-acquired infections, increasingly driven by drug-resistant bacteria. Rapidly pinpointing environmental reservoirs and transmission hotspots remains... Read more
Pathology
view channel
Biomarker Predicts Immunotherapy Response and Prognosis in Colorectal Cancer
Colorectal cancer is common and often lethal, and therapeutic decision-making is complicated by heterogeneous tumor microenvironments. Immunotherapy benefits only a small subset of patients, around 5%,... Read more
AI Improves Completeness of Complex Cancer Pathology Reports
Oncology teams increasingly rely on pathology reports that integrate histopathology, immunohistochemistry, and rapidly expanding biomarker testing. As patients live longer and undergo repeated analyses... Read more
AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more_image.png "Image: Through neoadjuvant therapy combining chemotherapy with immune checkpoint inhibitors (ICI) for 46 LAGC patients and single-cell transcriptome sequencing, researchers found that tumor cells in the treatment-sensitive group specifically upregulated MHC-II (tumor-specific major histocompatibility complex class II, tsMHC-II) molecules (photo courtesy of Science China Press)")
Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer mortality worldwide, with China bearing nearly half of the global burden. Only a subset of patients benefit from... Read moreTechnology
view channel
Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
Pre-analytical variation remains a leading source of inconsistent molecular test results and added costs, particularly when laboratories rely on multiple instruments and protocols. Standardizing nucleic... Read more
Noninvasive Sputum Test Detects Early Lung Cancer
Early detection remains critical for improving outcomes in lung cancer, yet clinicians increasingly encounter indeterminate pulmonary nodules found incidentally or through screening, complicating decision-making.... Read more
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channel
Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections
Clinicians often struggle to distinguish bacterial from viral infections at first presentation because symptoms overlap and definitive culture or molecular results can take hours or days.... Read more
